NAMI vs MAX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

NAMI

55.2
AI Score
VS
NAMI Wins

MAX

34.6
AI Score

Investment Advisor Scores

NAMI

55score
Recommendation
BUY

MAX

35score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric NAMI MAX Winner
Forward P/E 0 9.5877 Tie
PEG Ratio 0 0 Tie
Revenue Growth -31.9% 22.7% MAX
Earnings Growth 0.0% 75.4% MAX
Tradestie Score 55.2/100 34.6/100 NAMI
Profit Margin -23.9% 8.3% MAX
Beta 1.00 1.00 Tie
AI Recommendation BUY AVOID NEW MONEY NAMI

Relative Price Performance (Last 90 Days)

NAMI 1M: -24.2% · 3M: -46.6% MAX 1M: +40.3% · 3M: +8.0%

Current Technical Phase

NAMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.0%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $1.66

MAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 65.0 · Price: $14.16

Fundamentals Snapshot

Metric NAMI MAX
Market Cap — —
Forward P/E 0.0 7.7
Trailing P/E 0.9 7.8
Revenue (TTM) — —
Revenue Growth -0.3% 0.2%
Gross Margin 0.1% 0.1%
Operating Margin -0.1% 0.1%
EPS 1.93 1.82
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NAMI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.